Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Open to changes in new...

    Open to changes in new standards for food supplements: FSSAI

    Written by Ruby Khatun Khatun Published On 2017-07-07T09:19:57+05:30  |  Updated On 7 July 2017 9:19 AM IST

    New Delhi: Food regulator FSSAI on Thursday assured the food supplements and nutraceuticals industry that it is open to making changes in the new standards to support growth of the sector, but without compromising on consumers interest.


    The Food Safety and Standards (Health Supplements, Nutraceuticals, Food for Special Dietary Use, Food for Special Medical Purpose, Functional Food and Novel Food) Regulations was issued last December.


    Food Business Operators (FBOs) need to comply with these standards by January 1, 2018.


    Addressing a Assocham conference on nutraceuticals, Food Safety and Standards Authority of India (FSSAI) CEO Pawan Kumar Agarwal expressed concern over the increasing number of spurious food supplement products in the market.


    "We released standards on food supplements and nutraceuticals few months ago. There were some concerns from the industry but we went ahead and released the standards. But our effort is not to cast them in stone as these are evolving standards," Agarwal said.


    "I want to assure the industry that if there are concerns, we are still open to change that. We have 5-6 months time before this regulations come in force. So, hopefully, we will iron out differences," he said.


    On the sidelines, the FSSAI CEO said that it has got many representation from the industry seeking some changes in the regulations related to inclusion of ingredients.


    "Food supplements is a difficult sector to regulate. But for us consumers interest is paramount and non-negotiable," he said, asking manufacturers to be cautious in declaring any claims about the products.


    Stating that a large number of spurious products are available in the market, he said there is no "robust framework" for testing of food supplement products.


    FSSAI has set up a technical panel, which includes representation from industry as well, to prepare a framework for Good Manufacturing Practice (GMP).


    "We do hope that it will bring greater clarity to have a more robust ecosystem for manufacturing, processing and distribution of food supplements in the country," he said.


    Agarwal said there is immense opportunity in this industry, but cautioned that "bad name to food supplements sector by few dubious players can hamper the growth of this sunrise industry".


    Speaking at the event, Food Processing Secretary JP Meena said the size of this industry is currently USD 3-4 billion and is growing at 20 per cent.


    He said there is a great potential for this sector as the market is huge for these products in India as well as overseas.


    However, Meena said there is a need to keep the price of food supplements and nutraceuticals at an "affordable" level.


    He also spoke about challenges before the sector and said that consumer confidence about these products is "still to be gained".


    The industry should be in a position to verify claims made about these products through evidence, he said, adding that "traceability is important".


    He emphasised on industry focus on backward linkages to ensure traceability and also on organised cultivation of plants required for nutraceuticals production.


    Meena highlighted that the government has recently launched Rs 6,000 crore Sampada scheme to boost food processing and asked industry to avail benefit of this scheme.


    He asked food supplement industry to set up units in mega food parks instead of establishing standalone facilities.

    AssochamchangesConferenceconsumerFood regulatorFood Safety and Standards Authority of Indiafood supplementsFSSAIgood manufacturing practicesindustryJP Meenanew standardsnutraceuticalsPawan Kumar AgarwalSampada scheme
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok